This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Charter Medical Launches New EXP-Pak(TM) Cell Expansion Containers For Cellular Therapy Applications

MANCHESTER, Conn., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Charter Medical, Ltd., a division of Lydall, Inc., (NYSE:LDL) announced today that it has recently launched the new EXP-Pak™ cell expansion containers intended for the expansion and culture of non-adherent cells. The launch of this exciting new product family allows Charter Medical to provide enabling technology critical to the rapidly growing cellular therapy market. The family of closed-system cell expansion containers offers a broad size range from 500mL to 5L and end-user validated cell expansion rates and recovery.

Joe Petrosky, Vice President of Global Marketing and Sales for Charter Medical, stated, "We are excited with the launch of the EXP-Pak™ cell expansion product family. The EXP-Pak™ containers complement our closed-system solution approach and play a key role in supporting the development of new cellular therapies."

Dale Barnhart, President and CEO of Lydall, stated, "I am pleased with the launch of this product family for cellular therapy which represents a strategic growth opportunity. It further demonstrates our commitment to being the global supplier of choice as we grow our presence in this emerging segment."

About Lydall, Inc.

Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut. The Company, with operations in the U.S., France, and Germany and offices in Europe and Asia, focuses on specialty engineered products for the thermal/acoustical and filtration/separation markets. Charter Medical, Ltd., a Lydall subsidiary, is a vital fluids management company focused on providing products to separate, contain and transport vital fluids in the blood and cell therapy market and the biotech and pharmaceutical industries. Lydall® is a registered trademark of Lydall, Inc. in the U.S. and other countries. All product names are trademarks of Lydall, Inc. or Charter Medical, Ltd.

CONTACT: For further Charter Medical information:
         Dominic Clarke, Ph.D.
         Product Manager
         Cellular Therapy and Cryogenic Storage
         3948-A Westpoint Blvd.
         Winston-Salem, NC 27103
         Phone  336-768-6447
         Fax  336-774-1750
         DClarke@lydall.com
         www.CharterMedical.com
         
         For further information:
         David D. Glenn
         Director Business Development and
         Investor Relations
         Telephone  860-646-1233
         Facsimile  860-646-4917
         info@lydall.com
         www.lydall.com

company logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs